Zubairi, I;
Dean, E;
Molife, LR;
Lopez, J;
Ranson, M;
El-Khouly, F;
Savulsky, C;
... Evans, TRJ; + view all
(2016)
Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors.
Presented at: 2016 Jahrestagung der DGHO, OeGHO, SGMO und SGH, Leipzig, Germany.
Text
Kristeleit_DGHO BOLD-LF abstract_Submitted.pdf - Accepted Version Access restricted to UCL open access staff Download (241kB) |
Archive Staff Only
View Item |